-
In the first of a two-part series, Laura Whiting and Paul Abbott of Freshfields Bruckhaus Deringer examine how the UK has become a haven for FRAND disputes, discuss recent cases and look ahead to this autumn’s big UK Supreme Court hearing
-
Despite being criticised as contradictory and confusing, the Federal Circuit’s Section 101 case law since Alice provides some clear guidance that will assist practitioners, say Michael Kiklis, Shu Chen and Matthew Zapadka of Bass, Berry & Sims
-
During M&A, the importance of due diligence into a target’s IP cannot be overstated, say Katie McConnell, Emily Sharkey and Penelope Thornton of Hogan Lovells, who provide 10 top tips for investors
-
Tanya Varma and Eva Bishwal of Fidus Law Chambers provide a history lesson on the interaction between India’s trademark and design statutes and discuss what lies ahead
-
Matthew Werdegar of Keker, Van Nest & Peters examines current US efforts to curtail China’s theft of trade secrets and considers whether and what additional steps companies should take to protect themselves
-
Erick Robinson of Dunlap, Bennett & Ludwig examines three underused patent strategies for companies, including those in the US, to succeed in China
-
Following the UK’s introduction of a doctrine of equivalents, Paul England of Taylor Wessing looks at the potential application of aspects of German IP law to determine the breadth of the doctrine’s scope
-
Robert Reading of CompuMark examines some of the common perceptions of pharmaceutical trademarks and how they measure up in reality
-
Maria Engstrand and Magnus Johansson of Valea interview Haakon Thue Lie and Knut Jørgen Egelie who are conducting a PhD study on contracts between industry and universities and the balance between openness and trade secrets.
-
Masato Iida of Shiga examines examples of patent claims related to antibody drugs, assessing which data is included in claims
-
Wu Xiaoping and Hu Honghui of Wanhuida examine the methodology employed by the Patent Reexamination Board to determine non-obviousness of an improvement invention
-
Yujie Jin and Fei Lian of Liu Shen examine the data issues that arise from the Internet of Things and detail new laws and regulations concerning the protection of personal information
-
Youping Ma and Guoquan Yang of Bridgeon examine how AI can be protected by trade secrets, analysing which aspects of AI technologies should be safeguarded using this method
-
Max Walters delves into SPC referrals to the CJEU, asking lawyers why the topic is proving so controversial and why UK courts have taken it upon themselves to try to resolve issues
-
Cristina Biggi of Bugnion examines the introduction of the new SPC manufacturing waiver, including the process that led to its creation and the amendments it makes to the SPC regulation
-
Roman Larshin analyses a recent case concerning computer software and the important role of examination opinions in such matters
-
Magnus Johansson and Behdad Assadi of Valea examine the circumstances in which AI is patentable in Europe, analysing when AI makes a technical contribution to an invention and looking at two examples of AI
-
Ben Brigou and Jaap Mannaerts of NLO examine the different incentives the EU offers in order to encourage pharmaceutical innovation, including SPCs, regulatory measures and the Bolar exemption